OLMA
Olema Pharmaceuticals, Inc. · Healthcare
Director Cyrus Harmon sold $152K of Olema Pharmaceuticals, Inc.
Sold$152,100
$10.14Price
15,000Shares
−1%Stake
What OLMA did after the filing
- The stock from Wed, Sep 6 open, $12.68
- −15.9%
- S&P 500, same days
- −3.7%
Measured over 30 trading days, to the Oct 18 close.
Traded Wed, Aug 16. Filed Tue, Sep 5. Returns use the Sep 6 open and the Oct 18 close. Not investment advice.